- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SCOPE FLUIDICS Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TEMPUS AI | 35,510 | +2,07 % | Tempus AI (NASDAQ:TEM) Shares Down 5.7% Following Insider Selling | ||
| RECURSION PHARMACEUTICALS | 7,680 | +6,08 % | Recursion Pharmaceuticals Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules | Salt Lake City, Utah, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. ("Recursion") (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug... ► Artikel lesen | |
| QUANTUM-SI | 1,835 | +41,15 % | Quantum-Si präsentiert ProteoVue-Software für Proteinforschung | ||
| HUMACYTE | 5,130 | +13,75 % | Pre-market Movers: My Size, Nvni Group, Psyence Biomedical, Humacyte, PainReform | BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.55 A.M. ET).In the Green My Size, Inc. (MYSZ) is up over 372% at $6.43.
Nvni... ► Artikel lesen | |
| SCISPARC | 0,480 | +116,82 % | SciSparc Says AutoMax Receives First Delivery Of Vehicles From Jianghuai Automobile | ||
| JANUX THERAPEUTICS | 55,12 | -1,82 % | Pre-market Movers: Cheetah Net Supply Chain Service, NLS Pharmaceutics, PSQ Holdings, Janux Therapeutics, Coherus BioSciences | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.45 A.M. ET).In the Green Cheetah Net Supply Chain Service Inc. (CTNT) is up... ► Artikel lesen | |
| SUMMIT THERAPEUTICS | 19,260 | +1,37 % | Where Will Summit Therapeutics Be in 5 Years? | ||
| ADMA BIOLOGICS | 17,630 | +1,26 % | ADMA Biologics, Inc.: ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility | ||
| STRUCTURE THERAPEUTICS | 29,720 | +5,20 % | Structure Therapeutics Inc.: Structure Therapeutics Strengthens Executive Team with Promotion of Blai Coll, M.D., Ph.D. to Chief Medical Officer and Appointment of Ashley Hall, J.D. as Chief Development Officer | SAN FRANCISCO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for... ► Artikel lesen | |
| CG ONCOLOGY | 29,220 | +3,25 % | CG Oncology Inc.: CG Oncology Reports Second Quarter 2024 Financial Results and Provides Business Updates | - Final positive safety and efficacy findings from CORE-001 study of Cretostimogene Grenadenorepvec in combination with Pembrolizumab in BCG-Unresponsive NMIBC simultaneously published online by Nature... ► Artikel lesen | |
| VERA THERAPEUTICS | 42,760 | +2,00 % | Vera Therapeutics CEO Fordyce Marshall verkauft Aktien im Wert von 753.679 US-Dollar | ||
| KEROS THERAPEUTICS | 16,460 | -1,50 % | Biotech-Aktie Keros crasht brutal - dieser Pharma-Riese profitiert | Schock-Nachricht für Aktionäre der Biotech-Gesellschaft Keros Therapeutics: Das Unternehmen muss die Entwicklung des großen Hoffnungsträgers Cibotercept (KER-012) in höheren Dosisgruppen in einer Phase-2-Studie... ► Artikel lesen | |
| CANDEL THERAPEUTICS | 9,085 | +3,24 % | Hedge Fund and Insider Trading News: Simon Sadler, Stanley Druckenmiller, Warren Buffett, Caxton Associates, Millennium Management, Saba Capital, Candel Therapeutics Inc (CADL), NVIDIA Corp (NVDA), and More | ||
| SPRINGWORKS THERAPEUTICS | 36,730 | -0,22 % | SpringWorks Therapeutics, Inc.: SpringWorks Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights | - Achieved $49.3 million in OGSIVEO® (nirogacestat) net product revenue in the third quarter - - Long-term follow-up data from the Phase 3 DeFi trial of nirogacestat in adults with desmoid tumors... ► Artikel lesen | |
| ARVINAS | 18,570 | -0,85 % | Arvinas, Pfizer Report Positive Data From Phase 1b Study Of Vepdegestrant Combination Therapy | NEW YORK CITY (dpa-AFX) - Arvinas, Inc. (ARVN) and Pfizer Inc. (PFE), Tuesday announced preliminary data from the ongoing Phase 1b portion of the TACTIVE-U sub-study of Vepdegestrant in combination... ► Artikel lesen |
Das Unternehmen SCOPE FLUIDICS SA kann der Branche Biotechnologie zugeordnet werden. Der aktuelle Kurs liegt bei 31,300 Euro und damit +4,16 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SCOPE FLUIDICS SA finden Sie auf Wallstreet Online.
